Peter Conti and Johan Spoor agreed to resign as directors of FluoroPharma Medical Inc., effective Jan. 1, 2017.
The resignations are not due to any disagreements on any matter relating to the company's operations, policies and practices.
2 FluoroPharma directors resign
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective